The Medical Debt Exception: The Debt Nobody Chose and the Rule That Died
The Medical Debt Exception: The Debt Nobody Chose and the Rule That Died
Roughly 100 million Americans carry some form of medical debt, and at one point it represented 58% of the consumer debt in collections appearing on credit reports — a larger share than credit cards, auto loans, and every other category combined. That statistic is the entire policy problem in one line: the single largest source of derogatory credit information in the country is generated by illness rather than by borrowing. A federal rule finalized in January 2025 would have removed nearly all of it. In July 2025 a court vacated that rule and held something further — that federal law preempts the state statutes attempting the same thing. This report examines how medical debt became a credit reporting category, what survived, and what remains genuinely unresolved.
In this report
The core thesis
Credit reporting rests on an implicit premise: that how a person handled past obligations tells you something about how they'll handle future ones. Our thesis is that medical debt is the case where that premise is weakest, and the policy fight is really an argument about whether the credit reporting system should distinguish between debts people chose and debts that happened to them.
Three features make medical debt structurally unlike every other category on a credit report. It's involuntary — nobody comparison-shops an emergency room. The price is unknown at the point of decision, and frequently unknown for months afterward, which makes the ordinary consumer-credit assumption of informed agreement inapplicable. And a large share of it is disputed or erroneous rather than owed, arising from insurance processing, coding, and coordination-of-benefits problems that the patient neither caused nor can readily resolve — the billing dynamics our medical billing guide documents.
The second half of the thesis concerns what happened when policy tried to act on that observation. The federal rule was vacated on statutory authority grounds rather than on the merits of the underlying argument — the court held the Bureau had exceeded what the Fair Credit Reporting Act permits, not that medical debt belongs on credit reports. That distinction matters, because it means the substantive question remains open while the regulatory route to answering it has narrowed considerably. And the same decision reached further than the rule itself, holding that federal law preempts state efforts in the same direction — which is the part with the longest consequences.
The largest single source of derogatory credit information in America is generated by illness rather than by borrowing. Every argument in this area follows from that sentence.
Why medical debt is structurally different
Set the policy aside and compare the transaction itself against ordinary consumer credit:
| Ordinary consumer debt | Medical debt | |
|---|---|---|
| Choice | The consumer decided to borrow | Frequently no decision was possible |
| Price known upfront | Yes — disclosed before agreement | Rarely, and sometimes not for months |
| Underwriting | The creditor assessed ability to pay | None — care is delivered first |
| Amount certainty | Fixed at origination | Subject to insurance adjudication, appeals, and revision |
| Error rate | Low relative to volume | High — billing, coding, and coverage disputes are routine |
| Correlation with financial behavior | Direct | Attenuated — it tracks health events |
The row that carries the most weight is the fourth. A medical bill is frequently not a fixed obligation but a provisional one, subject to insurance processing that can take months and can change the amount owed to zero. A consumer who receives a bill, disputes it correctly, and has it adjusted has done nothing wrong — but if it reached a collection agency and was furnished during that period, the credit file records a delinquency that reflects an administrative process rather than a payment failure.
That's the case for treating the category differently, and it's a stronger case than the general "people shouldn't be punished for getting sick" framing, because it's about data quality rather than about sympathy.
The scale
- Roughly 100 million Americans carry some form of medical debt.
- In 2021, medical debt made up 58% of consumer debt in collections appearing on credit reports — the single largest category.
- Roughly a quarter of debt collection industry revenue in 2023 came from health care debt, per market research estimates.
- The 2022 voluntary bureau changes were estimated to remove approximately 70% of outstanding medical debt from credit reports.
Two observations. The 58% figure is the one that reframes the topic — this isn't a niche category, it's the dominant one, which means decisions about how to treat it affect the composition of American credit reports more than any other single policy choice available. And the 70% removal figure demonstrates that most of the practical change in this area happened before the rulemaking, through voluntary industry action, which is why the rule's vacatur changed less than headlines suggested.
What the bureaus did voluntarily
In 2022 and 2023, the three major credit bureaus adopted changes that remain the operative protections today — and critically, they don't depend on any federal rule surviving in court:
- Paid medical collections are no longer reported, regardless of amount and regardless of how long they took to pay. Previously a paid medical collection could sit on a file for years.
- Unpaid medical collections under $500 are not reported, paid or unpaid.
- A grace period of roughly twelve months applies before an unpaid medical collection can appear at all, giving the consumer time to resolve insurance disputes, apply for financial assistance, or negotiate.
These were adopted under regulatory and state pressure rather than spontaneously, which is itself worth noting: the threat of rulemaking produced most of the practical relief that the rulemaking itself failed to deliver. That's a recurring dynamic in consumer finance and one worth registering — voluntary industry action taken in the shadow of proposed regulation frequently survives the regulation's legal defeat, because it isn't dependent on the legal authority that was challenged.
The twelve-month grace period deserves particular emphasis for consumers, because it's the most actionable of the three. A medical bill that goes to collections doesn't hit your credit file immediately — there's a window, and it's long enough to do something with.
The rule and the vacatur
The sequence, precisely:
June 2024: the CFPB proposed a rule barring credit reporting agencies from including medical debt and related collection tradelines on consumer reports, and prohibiting lenders from using medical debt collection information in credit decisions. The stated rationale was that medical debts are frequently inaccurate, coerced, or unreflective of creditworthiness.
January 7, 2025: the rule was finalized as the Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information, amending Regulation V.
January 2025: Cornerstone Credit Union League and the Consumer Data Industry Association sued, arguing the rule exceeded the Bureau's statutory authority under the Fair Credit Reporting Act and was arbitrary and capricious.
February 2025: following a change in Bureau leadership, the court granted a CFPB motion staying the rule.
April 2025: the CFPB and the plaintiffs jointly asked the court to vacate the rule — the agency that wrote it now asking for its removal.
July 11, 2025: the U.S. District Court for the Eastern District of Texas vacated the rule, agreeing that it exceeded the Bureau's statutory authority and was contrary to the FCRA because it purported to prohibit the furnishing and consideration of coded medical debt information the statute contemplates.
Two features of this sequence are worth naming. The rule never took effect — it was finalized and vacated without an operative compliance period, so nothing was implemented and then withdrawn. And the vacatur came on a joint motion, which is unusual: the agency did not defend its own rule. That means the substantive arguments were never adjudicated on their merits, and the holding is about authority rather than about whether medical debt belongs on credit reports.
The pattern here rhymes with the subscription rulemaking our negative option analysis describes: a rule defeated on legal grounds does not settle the underlying question, and the conduct at issue remains subject to whatever other authority exists.
The preemption holding
The part of the decision with the longest reach was not the vacatur. The court also concluded that the Fair Credit Reporting Act expressly preempts state laws attempting to impose similar restrictions on medical debt credit reporting.
Why that matters enormously: the states had been acting independently of the federal rulemaking, legislating directly on furnishers and consumer reporting agencies under their own authority. A preemption holding puts those statutes in direct tension with federal law — which is a different and more consequential outcome than simply removing a federal rule.
The tension is genuine and unresolved. State laws regulating furnishers remain on the books and continue to be enacted; the preemption question determines whether they can operate. For a consumer in one of those states, the practical answer to "is my medical debt protected" currently depends on an unsettled legal question rather than on a readable rule — which is an unusually unsatisfying position for a consumer protection to be in.
This is the mirror image of the fragmentation our regulatory map documents elsewhere. Usually the story is no federal rule and fifty state ones. Here it's a federal statute arguably foreclosing the state ones while the federal rule that would have gone further has been struck down — producing less protection than either level intended.
Fifteen states in tension
As of mid-2026, roughly fifteen states have enacted some form of restriction or ban on medical debt credit reporting, with effective dates clustering across 2023 through 2025 — New York, Colorado, Connecticut, Virginia, Minnesota, New Jersey, Illinois, California, Maine, Rhode Island, Vermont, and Washington among those already in effect, with others enacted and phasing in.
The structural features of these laws:
- They regulate furnishers and reporting agencies directly under state authority, rather than depending on the federal rule.
- They vary in scope — some prohibit reporting entirely, some restrict use in lending decisions, some limit collection practices alongside reporting.
- They generally arrived before or during the federal rulemaking, which is why they survived its collapse.
- They now face the preemption question raised by the July 2025 decision.
The practical guidance for a consumer is uncomfortable but honest: check your state's current position and check your credit reports, because the two may not match. A state ban that furnishers are complying with produces protection regardless of the legal debate; one that furnishers have stopped honoring on preemption grounds produces none. The only reliable way to know which applies to you is to look at your own file.
Does it predict repayment?
The empirical question underneath everything, stated fairly in both directions.
The case that it predicts poorly: medical debt arises from health events rather than financial decisions, its amounts are frequently disputed or erroneous, and it appears on files of consumers whose payment behavior on chosen obligations is fine. If the purpose of a credit report is to indicate how someone handles credit, a category generated by illness is a noisy signal. Research supporting the rule found medical debt less predictive than comparable non-medical debt of the same size.
The case that it carries information: an unpaid obligation is an unpaid obligation, and the reason it went unpaid is at least partly about capacity — which is exactly what a lender is assessing. A consumer with $8,000 in unpaid medical bills has an $8,000 claim against their future income regardless of its origin, and removing that from view means lending to someone whose obligations you can't see. Opponents also argued that removing a large data category degrades assessment for everyone, including by pushing lenders toward less transparent alternatives.
Where we land: both are partly right, and the disagreement is less empirical than it appears. The predictive-value question depends on what you're predicting. Medical debt is a weak signal of financial character and a real signal of financial capacity, and the credit reporting system doesn't distinguish those. That's the same conflation our thin-file analysis identifies from the other direction — where absence of data gets read as risk. In both cases the system's vocabulary is too coarse for the question being asked of it.
The more interesting point for lenders: cash flow data resolves this cleanly. A lender assessing whether an applicant can service a new obligation, using the account-level evidence our cash flow guide describes, sees actual capacity including whatever medical payments are actually being made — without needing to infer capacity from a derogatory tradeline of uncertain accuracy. The policy fight is partly a proxy for a data-quality problem that better data makes less pressing.
What a consumer should actually do
Given the unsettled legal position, the practical steps are unchanged and worth stating plainly:
- Never pay a first medical bill without reviewing it. Request an itemized bill and check it against your explanation of benefits — the error rate is the whole reason this category is contested.
- Use the twelve-month window. A medical collection generally can't appear on your report for roughly a year, which is time to dispute, appeal an insurance denial, apply for financial assistance, or negotiate.
- Ask about charity care and financial assistance explicitly. Nonprofit hospitals generally have policies, eligibility is broader than most patients assume, and it is very seldom volunteered.
- Appeal insurance denials. A meaningful share are overturned, and an overturned denial eliminates the debt rather than reducing it.
- Check whether the bureau protections apply — paid collections and unpaid amounts under $500 should not appear, and if they do, that's a dispute with a clear basis.
- Dispute inaccuracies through the process in our error correction guide, and specifically check whether the collector can validate the debt.
- Don't put medical debt on a credit card to make it go away. That converts a debt with no interest, weak collection leverage, and possible charity care eligibility into revolving debt at rate — the conversion problem our equity extraction report examines in its larger form.
- Check your state's position and your own reports, since the two may diverge.
Scenarios and what we're watching
| Scenario | Shape of the world | Signposts |
|---|---|---|
| Base case — voluntary standards hold | Bureau changes remain the operative protection; the preemption question limits state effect; medical debt stays on reports above $500 and unpaid | Bureau policy changes; furnisher compliance with state laws; medical collection volumes on files |
| Legislative case | Congress acts directly, which is the only route left that survives the authority holding | Federal bills addressing medical debt reporting; hearings; industry positioning |
| State resolution case | Preemption is resolved in favor of state authority, restoring the effect of fifteen state statutes and encouraging more | Appellate treatment of the preemption holding; new state enactments; furnisher practice by state |
What we're watching: how the preemption holding is treated in subsequent litigation, since it determines whether fifteen state laws have force; bureau voluntary policy, which delivered most of the actual change and could deliver more or less without any legal process; medical collection volumes on credit files, which measures the real-world outcome independent of the legal debate; and lender use of cash flow data, which reduces the stakes of the whole question by making the derogatory tradeline less load-bearing.
A rule was written to solve a data quality problem, struck down for exceeding authority, and the underlying problem is unchanged: the largest category of negative information on American credit reports is generated by a system where prices are unknown, bills are frequently wrong, and nobody chose to participate.
Frequently asked questions
It can be. The federal rule was vacated in July 2025 and never took effect, but voluntary bureau changes remain: paid medical collections aren't reported, unpaid collections under $500 aren't reported, and roughly twelve months pass before a medical collection can appear.
On July 11, 2025, the Eastern District of Texas vacated it on the joint request of the Bureau and the plaintiffs, holding it exceeded the CFPB's authority and was contrary to the FCRA. The merits of the underlying argument were never adjudicated.
Unsettled. Fifteen states have enacted restrictions regulating furnishers directly, but the same July 2025 decision held the FCRA preempts state laws imposing similar restrictions — putting them in tension with federal law.
Less well than comparable non-medical debt. It's a weak signal of financial character and a real signal of capacity — and the credit reporting system doesn't distinguish those two things.
Key takeaways
- Roughly 100 million Americans carry medical debt, which represented 58% of consumer collections debt on credit reports — the largest single category.
- Voluntary bureau changes removed an estimated 70% of it and remain in effect independent of any federal rule: no paid collections, nothing under $500, and a roughly twelve-month grace period.
- The federal rule was vacated July 11, 2025 on the Bureau's own joint motion, for exceeding statutory authority — not on the merits of whether medical debt belongs on reports.
- The same decision held the FCRA preempts state laws imposing similar restrictions, putting fifteen state statutes in unresolved tension with federal law.
- Medical debt is structurally unlike other debt: involuntary, unpriced at decision, provisional in amount, and high in error rate.
- Use the twelve-month window — request itemized bills, appeal denials, and ask about charity care before anything reaches your credit file.
This report is for general information only and does not constitute legal or financial advice. The legal position described reflects publicly reported developments as of publication and includes an unresolved preemption question; verify current federal and state requirements before relying on any description here.